MICROPORT NEURO (02172) Schedules 25 Mar 2026 Board Meeting to Approve FY 2025 Results and Consider Final Dividend

Bulletin Express03-13

MicroPort NeuroScientific Corporation (stock code: 02172) has announced that its board of directors will convene on 25 March 2026. The agenda includes:

• Reviewing and approving the consolidated financial results for the year ended 31 December 2025.

• Considering the declaration of a final dividend, if any.

• Addressing other routine corporate matters.

The meeting will be chaired by Dr. Zhang Jie, Chairman and Non-executive Director. The board currently comprises two Executive Directors, three Non-executive Directors, and four Independent Non-executive Directors.

The company will publish the audited FY 2025 results and any dividend decision following the board’s approval.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment